BJ, S., A, G., E, A., JP, L., K, T., Y, W., & V, V. (2026). Effect of Concomitant Medications on Adverse Event Frequency, Severity, and Time to Resolution in a Cenobamate Open-Label Trial. European journal of neurology, 33(7), e70705. https://doi.org/10.1111/ene.70705
Chicago Style (17th ed.) CitationBJ, Steinhoff, Gil-Nagel A, Alvarez-Baron E, Leach JP, Thangavelu K, Winter Y, and Villanueva V. "Effect of Concomitant Medications on Adverse Event Frequency, Severity, and Time to Resolution in a Cenobamate Open-Label Trial." European Journal of Neurology 33, no. 7 (2026): e70705. https://doi.org/10.1111/ene.70705.
MLA (9th ed.) CitationBJ, Steinhoff, et al. "Effect of Concomitant Medications on Adverse Event Frequency, Severity, and Time to Resolution in a Cenobamate Open-Label Trial." European Journal of Neurology, vol. 33, no. 7, 2026, p. e70705, https://doi.org/10.1111/ene.70705.